Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen Masayuki InubushiHiroyuki MiuraRyogo Minamimoto Invited Review Article Open access 11 November 2020 Pages: 879 - 883
The quantification of PET–CT radiotracers to determine minimal scan time using quadratic formulation Mohamad Aminudin SaidMarianie MusarudinNur Farahiyah Zulkaffli Original Article 03 November 2020 Pages: 884 - 891
Causes of false negatives in technetium-99 m methoxyisobutylisonitrile scintigraphy for hyperparathyroidism: influence of size and cysts in parathyroid lesions Shiro IshiiShigeyasu SugawaraHiroshi Ito Original Article 12 September 2020 Pages: 892 - 898
Reactor produced [64Cu]CuCl2 as a PET radiopharmaceutical for cancer imaging: from radiochemistry laboratory to nuclear medicine clinic Rubel ChakravartyPriyalata ShettySudipta Chakraborty Original Article 13 October 2020 Pages: 899 - 910
Value of 18F-FDG PET/CT for prognostic stratification in patients with primary intestinal diffuse large B cell lymphoma treated with an R-CHOP-like regimen Chong JiangYue TengJingyan Xu Original Article 15 October 2020 Pages: 911 - 919
Relapse-free survival after adjuvant radioactive iodine therapy in patients with differentiated thyroid carcinoma with a microscopically positive tumor margin Ken WatanabeTakao IgarashiHiroya Ojiri Original Article 17 September 2020 Pages: 920 - 925
The utility of a deep learning-based algorithm for bone scintigraphy in patient with prostate cancer Yuki AokiMichihiro NakayamaAtsutaka Okizaki Original Article 21 September 2020 Pages: 926 - 931
Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT Meltem CaglarMurat TuncelErdem Karabulut Original Article 25 September 2020 Pages: 932 - 941
Metabolic changes in breast cancer on dual-time-point 18F-FDG PET/CT imaging according to primary tumor uptake and background parenchymal enhancement Hye Ok KimBom Sahn KimHai-Jeon Yoon Original Article 24 September 2020 Pages: 942 - 951
Comparison of diagnostic accuracy between [18F]FDG PET/MRI and contrast-enhanced MRI in T staging for oral tongue cancer Masafumi KannoTetsuya TsujikawaShigeharu Fujieda Original Article 10 October 2020 Pages: 952 - 959
Value of volumetric and textural analysis in predicting the treatment response in patients with locally advanced rectal cancer Nazlı Pınar Karahan ŞenAyşegül AksuGamze Çapa Kaya Original Article 19 September 2020 Pages: 960 - 967
FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer Romain-David SebanJean-Baptiste AssieLaurence Champion Short Communication 18 October 2020 Pages: 968 - 974